228 related articles for article (PubMed ID: 24124521)
1. Distinct effects of EGFR ligands on human mammary epithelial cell differentiation.
Mukhopadhyay C; Zhao X; Maroni D; Band V; Naramura M
PLoS One; 2013; 8(10):e75907. PubMed ID: 24124521
[TBL] [Abstract][Full Text] [Related]
2. Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue.
Pasic L; Eisinger-Mathason TS; Velayudhan BT; Moskaluk CA; Brenin DR; Macara IG; Lannigan DA
Genes Dev; 2011 Aug; 25(15):1641-53. PubMed ID: 21828273
[TBL] [Abstract][Full Text] [Related]
3. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.
Bade LK; Goldberg JE; Dehut HA; Hall MK; Schwertfeger KL
J Cell Sci; 2011 Sep; 124(Pt 18):3106-17. PubMed ID: 21868365
[TBL] [Abstract][Full Text] [Related]
4. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development.
Luetteke NC; Qiu TH; Fenton SE; Troyer KL; Riedel RF; Chang A; Lee DC
Development; 1999 Jun; 126(12):2739-50. PubMed ID: 10331984
[TBL] [Abstract][Full Text] [Related]
5. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.
Sternlicht MD; Sunnarborg SW
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):181-94. PubMed ID: 18470483
[TBL] [Abstract][Full Text] [Related]
6. Derivation of myoepithelial progenitor cells from bipotent mammary stem/progenitor cells.
Zhao X; Malhotra GK; Band H; Band V
PLoS One; 2012; 7(4):e35338. PubMed ID: 22514728
[TBL] [Abstract][Full Text] [Related]
7. Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.
Nickerson NK; Mill CP; Wu HJ; Riese DJ; Foley J
Oncol Res; 2013; 20(7):303-17. PubMed ID: 23879171
[TBL] [Abstract][Full Text] [Related]
8. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix.
Zhu J; Shimizu E; Zhang X; Partridge NC; Qin L
J Cell Biochem; 2011 Jul; 112(7):1749-60. PubMed ID: 21381079
[TBL] [Abstract][Full Text] [Related]
9. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
[TBL] [Abstract][Full Text] [Related]
10. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
[TBL] [Abstract][Full Text] [Related]
11. Influence of terminal differentiation and PACAP on the cytokine, chemokine, and growth factor secretion of mammary epithelial cells.
Csanaky K; Doppler W; Tamas A; Kovacs K; Toth G; Reglodi D
J Mol Neurosci; 2014 Jan; 52(1):28-36. PubMed ID: 24323361
[TBL] [Abstract][Full Text] [Related]
12. Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor.
Baldys A; Göoz M; Morinelli TA; Lee MH; Raymond JR; Luttrell LM; Raymond JR
Biochemistry; 2009 Feb; 48(7):1462-73. PubMed ID: 19173594
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor regulates normal urothelial regeneration.
Daher A; de Boer WI; El-Marjou A; van der Kwast T; Abbou CC; Thiery JP; Radvanyi F; Chopin DK
Lab Invest; 2003 Sep; 83(9):1333-41. PubMed ID: 13679441
[TBL] [Abstract][Full Text] [Related]
14. Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers.
Kariagina A; Xie J; Leipprandt JR; Haslam SZ
Horm Cancer; 2010 Oct; 1(5):229-44. PubMed ID: 21258428
[TBL] [Abstract][Full Text] [Related]
15. Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells.
Ma L; Gauvillé C; Berthois Y; Degeorges A; Millot G; Martin PM; Calvo F
Int J Cancer; 1998 Sep; 78(1):112-9. PubMed ID: 9724102
[TBL] [Abstract][Full Text] [Related]
16. Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop.
Willmarth NE; Baillo A; Dziubinski ML; Wilson K; Riese DJ; Ethier SP
Cell Signal; 2009 Feb; 21(2):212-9. PubMed ID: 18951974
[TBL] [Abstract][Full Text] [Related]
17. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.
Sternlicht MD; Sunnarborg SW; Kouros-Mehr H; Yu Y; Lee DC; Werb Z
Development; 2005 Sep; 132(17):3923-33. PubMed ID: 16079154
[TBL] [Abstract][Full Text] [Related]
18. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin.
Yang N; Morrison CD; Liu P; Miecznikowski J; Bshara W; Han S; Zhu Q; Omilian AR; Li X; Zhang J
Cell Cycle; 2012 Aug; 11(15):2922-30. PubMed ID: 22825057
[TBL] [Abstract][Full Text] [Related]
19. Amphiregulin exosomes increase cancer cell invasion.
Higginbotham JN; Demory Beckler M; Gephart JD; Franklin JL; Bogatcheva G; Kremers GJ; Piston DW; Ayers GD; McConnell RE; Tyska MJ; Coffey RJ
Curr Biol; 2011 May; 21(9):779-86. PubMed ID: 21514161
[TBL] [Abstract][Full Text] [Related]
20. Reversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system.
Fukuda S; Nishida-Fukuda H; Nanba D; Nakashiro K; Nakayama H; Kubota H; Higashiyama S
Sci Rep; 2016 Feb; 6():20209. PubMed ID: 26831618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
